Company CVAbout Beta Drugs Ltd 
Beta Drugs Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Beta Drugs Limited was incorporated as a private limited company with the name "Beta Drugs Private limited" at Himachal Pradesh on September 21, 2005. Subsequently, the company was converted in to public limited company and the name of the company was changed to "Beta Drugs Limited" on August 11, 2017 Beta Drugs is a part of Adley Group.
Company Coordinates
Company Details
Village Nandpur , Baddi Himachal Pradesh : 174101
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 10.09 Cr
Number of Shares
1.01 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
25-Mar-2025
1.01
10.09
480693
10
Bonus Issue
30-Jun-2019
96.14
9.61
319046
10
Allotment of Equity To Others
11-Oct-2017
86.5
8.65
2296000
10
Public Issues
16-Aug-2017
63.53
6.35
394500
10
Right Issues
25-Jul-2017
59.59
5.96
4949000
10
Bonus
31-Oct-2014
10.1
1.01
250000
10
Right Issues
19-Oct-2014
7.6
0.76
250000
10
Right Issues
14-Oct-2014
5.1
0.51
250000
10
Right Issues
12-Oct-2014
2.6
0.26
250000
10
Right Issues
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 7 FIIs (1.14%)
Promoter with highest holding
Neeraj Batra (64.13%)
Highest Public shareholder
Suryavanshi Commotrade Private Limited (6.74%)
Individual Investors Holdings
21.78%
Board of Directors
Management
Designation
Remuneration
Balwant Singh.
Whole-time Director
0
Varun Batra
Joint Managing Director
84.0 lacs
Rahul Batra
Chairperson & M D
84.0 lacs
Manmohan Khanna
Independent Director
0
Rohit Parti
Independent Director
0
Rajni Brar
Company Sec. & Compli. Officer
0
Seema Chopra
Whole-time Director
6.87 lacs
Ashutosh Shukla
Whole-time Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Chemicals and Bulk Drugs - Traded
50.57
100.00%
Chemicals and Bulk Drugs - Traded
Stock DNARevenue and Profits:
Net Sales:
87 Cr
(Quarterly Results - Dec 2025)
Net Profit:
9 Cr
Pharmaceuticals & Biotechnology
INR Cr (Micro Cap)
23.00
NA
0.00%
0.00
0.00%
0.00
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
